Serono Drug Patent Portfolio
Serono owns 1 orange book drug protected by 1 US patent Given below is the list of Serono's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5767067 | Follicle stimulating hormone and pharmaceutical compositions containing same | 16 Jun, 2015 | Expired |
Serono's Family Patents
Clinical Trials
Recent Clinical Trials by Serono:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501) | EMD Serono Research & Development Institute, Inc. | NA |
ACTIVE NOT RECRUITING
(Sep 1, 2026)
| PHASE1 |
| A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03) | EMD Serono Research & Development Institute, Inc. | NA |
RECRUITING
(Aug 1, 2026)
| PHASE3 |
| Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) | EMD Serono Research & Development Institute, Inc. | NA |
ACTIVE NOT RECRUITING
(Jul 1, 2026)
| PHASE1 |
Serono Drug List
Given below is the complete list of Serono's drugs and the patents protecting them.
1. Fertinex
Fertinex is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5767067 | Follicle stimulating hormone and pharmaceutical compositions containing same |
16 Jun, 2015
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fertinex's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List